Emergence of daptomycin-resistant VRE: Experience of a single institution

Infection Control and Hospital Epidemiology

Volumn 32, Issue 4, 2011, Pages 391-394

  Kamboj, Mini ^a   Cohen, Nina ^a   Gilhuley, Kathleen ^a   Babady, N Esther ^a   Seo, Susan K ^a   Sepkowitz, Kent A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CANCER CENTER; CHILD; CLINICAL ARTICLE; EMPIRICAL RESEARCH; ENTEROCOCCAL INFECTION; FEMALE; HUMAN; MALE; NONHUMAN; PRESCHOOL CHILD; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEOPLASMS; VANCOMYCIN RESISTANCE;

EID: 79952611743     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/659152     Document Type: Article

References (11)

1. National Nosocomial Infections Surveillance (NNIS) System. NNIS report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470-485.
2. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41(3):327-333. (Pubitemid 41022109)
3. Sader HS, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis 2009;65(2):158-162.
4. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing - Twentieth Information Supplement. Wayne, PA: CLSI; 2010. CLSI document M100-S20.
5. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33(9):2233-2239.
6. Silverman JA, Oliver N, Andrew T, Li T. Resistance studies with daptomycin. Antimicrob Agents Chemother 2001;45(6):1799-1802. (Pubitemid 32466351)
7. Montero CI, Stock F, Murray PR. Mechanisms of resistance to daptomycin in Enterococcus faecium. Antimicrob Agents Chemother 2008;52(3):1167-1170. (Pubitemid 351358408)
8. Lesho EP, Wortmann GW, Craft D, Moran KA. De novo daptomycin nonsusceptibility in a clinical isolate. J Clin Microbiol 2006;44(2):673. (Pubitemid 43222282)
9. Fraher MH, Corcoran GD, Creagh S, Feeney E. Daptomycin-resistant Enterococcus faecium in a patient with no prior exposure to daptomycin. J Hosp Infect 2007;65(4):376-378. (Pubitemid 46477977)
10. Lewis JS II, Owens A, Cadena J, Sabol K, Patterson JE, Jorgensen JH. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother 2005; 49(4):1664-1665. (Pubitemid 40463418)
11. Long JK, Choueiri TK, Hall GS, Avery RK, Sekeres MA. Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin Proc 2005;80(9):1215-1216. (Pubitemid 41233359)